MBF THERAPEUTICS
MBF Therapeutics is a clinical-stage animal health company focusing on the development of gene-based, immunotherapeutic vaccines for use in veterinary medicine. Using proprietary vaccine platform and delivery system technology, MBF Therapeutics’ checkpoint inhibitor therapies have the potential of transforming the treatment of cancer and prevention of infectious diseases in companion animals and livestock.
MBF THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics Veterinary
Founded:
2008-01-01
Address:
Ambler, Pennsylvania, United States
Country:
United States
Website Url:
http://www.mbftherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
215-620-3699
Email Addresses:
[email protected]
Total Funding:
595 K USD
Technology used in webpage:
LetsEncrypt Apache Unified Layer MailChimp BlueHost
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Cognition Therapeutics
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Neos Therapeutics
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
Current Employees Featured
Founder
Investors List
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - MBF Therapeutics
StartUp PHL
StartUp PHL investment in Seed Round - MBF Therapeutics
Ben Franklin Technology Partners
Ben Franklin Technology Partners investment in Grant - MBF Therapeutics
Official Site Inspections
http://www.mbftherapeutics.com
- Host name: box5857.bluehost.com
- IP address: 162.241.24.83
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "MBF Therapeutics"
MBF Theraupeutics
MBF Therapeutics is an immunotherapeutic animal health company focused on the use of its innovative T-Maxâ„¢ DNA vaccine platform to create disruptive products for infectious disease …See details»
MBF Theraupeutics - mbftherapeutics.com
MBFT Organization Structure. MBF Therapeutics is prioritizing the discovery, creation, development and commercialization of animal health immunotherapeutics and using the …See details»
MBF Theraupeutics - mbftherapeutics.com
MBF Therapeutics is an immunotherapeutic animal health company focused on the use its innovative T- Maxâ„¢ DNA vaccine platform to create disruptive products for infectious disease …See details»
MBF Therapeutics - Crunchbase Company Profile
MBF Therapeutics is a clinical-stage animal health company focusing on the development of gene-based, immunotherapeutic vaccines for use in veterinary …See details»
MBF Therapeutics Inc. | LinkedIn
MBF Therapeutics is an immunotherapeutics company focused on animal applications of its innovative T-Maxâ„¢ immunotherapeutic DNA vaccine platform. In addition, there are significant...See details»
MBF Therapeutics Inc.: Contact Details and Business Profile
MBF Therapeutics is an immunotherapeutics company focused on animal applications of its innovative T-Maxâ„¢ immunotherapeutic DNA vaccine platform. In addition, there are significant …See details»
MBF Therapeutics - VentureRadar
Website: http://www.mbftherapeutics.com/ Develops immunotherapeutic animal health products using a DNA vaccine platform for infectious diseases and cancer, with potential human …See details»
MBF Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Explore MBF Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
MBF Therapeutics | Life Sciences PA - Default Site
Www.mbftherapeutics.com About Initial development is focused on highly efficacious, universal vaccines that prevent significant current and new infectious diseases in animals with …See details»
MBF Therapeutics - Ben Franklin Technology Partners
MBF Therapeutics Inc. (MBFT) is a veterinary oncology company developing innovative and highly effective immunotherapies for cancer and infectious diseases in companion animals and …See details»
MBF Therapeutics - PitchBook
Developer of a DNA vaccine platform designed to create products for the infectious disease animal health markets.See details»
MBF Therapeutics Inc. - Company Profile & Staff Directory
MBF Therapeutics is an immunotherapeutics company focused on animal applications of its innovative T-Maxâ„¢ immunotherapeutic DNA vaccine platform. In addition, there are significant …See details»
MBF Theraupeutics - mbftherapeutics.com
July 23, 2020 – Ambler, PA – MBF Therapeutics, a leader in the development of DNA-based immunotherapeutic checkpoint inhibitor vaccines, formed a collaboration of life science …See details»
MBF Therapeutics Company Profile - The Business Journals
Jan 14, 2022 · mbftherapeutics.com. 215-620-3699. 640 Woodbrook Dr., Ambler, PA 19002 Ownership Private. In the news. Jan 14, 2022. Lab Notes: Strata Skin Sciences makes …See details»
MBF Therapeutics - Overview, News & Similar companies
MBF Therapeutics contact info: Phone number: (215) 620-3699 Website: www.mbftherapeutics.com What does MBF Therapeutics do? MBF Therapeutics Inc. (MBFT) …See details»
MBF Therapeutics - Products, Competitors, Financials, Employees ...
MBF Therapeutics operates as an immunotherapeutic animal health company in the biotechnology industry. Use the CB Insights Platform to explore MBF Therapeutics's full profile.See details»
Thomas Tillett - MBF Therapeutics Inc. | LinkedIn
· Experience: MBF Therapeutics Inc. · Education: University of North Carolina at Chapel Hill · Location: Ambler · 500+ connections on LinkedIn. View Thomas Tillett’s profile on LinkedIn, a...See details»
Press Release - MBF Therapeutics
MBF Therapeutics has developed and patented an innovative, proprietary T-Max PrecisionTM DNA vaccine platform to deliver vaccines mucosally that provide safe, durable, broad cross …See details»
MBF Therapeutics And Lankenau Institute for Medical Research …
Our portfolio includes targeted gene-based and small molecule products with well-understood mechanisms of action that specifically disrupt tumor cell metabolism and/or modulate immune …See details»
FOR RELEASE January 5, 2022 - mbftherapeutics.com
The world’s food supply. MBFT technology promises a more effective, longer-lasting, polyvalent, readily adaptable and straightforward-to-manufacture vaccine platform to block infection and …See details»